Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

被引:3
作者
Bartziokas, Konstantinos [1 ,2 ]
Papathanasiou, Evgenia [2 ]
Papaioannou, Andriana I. I. [2 ]
Papanikolaou, Ilias [3 ]
Antonakis, Emmanouil [3 ]
Makou, Ioanna [3 ]
Hillas, Georgios [4 ]
Karampitsakos, Theodoros [4 ]
Papaioannou, Ourania [4 ]
Dimakou, Katerina [4 ]
Apollonatou, Vasiliki [2 ]
Verykokou, Galateia [2 ]
Papiris, Spyros [2 ]
Bakakos, Petros [5 ]
Loukides, Stelios [2 ]
Kostikas, Konstantinos [1 ]
机构
[1] Univ Ioannina, Resp Med Dept, Ioannina 45110, Greece
[2] Natl & Kapodistrian Univ Athens, Resp Med Dept 2, Athens 10679, Greece
[3] Corfu Gen Hosp, Resp Med Dept, Corfu 49100, Greece
[4] Sotiria Chest Hosp, Resp Med Dept 5, Athens 11527, Greece
[5] Natl & Kapodistrian Univ Athens, Resp Med Dept 1, Athens 10676, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词
COPD; exacerbations; eosinophils; hospital admission; non-invasive ventilation; OBSTRUCTIVE PULMONARY-DISEASE; HOSPITALIZED EXACERBATIONS; MECHANICAL VENTILATION; BLOOD EOSINOPHILS; INFECTION; OUTCOMES;
D O I
10.3390/jpm13040686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/mu L, was evaluated. Results Subjects with blood eosinophil number < 150 k/mu L had a more severe disease on admission compared to subjects with >= 150 k/mu L, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO2/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = -0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO2/FiO(2) (p < 0.001, r = -0.248), and with duration of hospital stay (p < 0.001, r = -0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/mu L was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Long-Term Domiciliary Noninvasive Ventilation for COPD
    Owens, Robert L.
    [J]. RESPIRATORY CARE, 2021, 66 (07) : 1120 - 1127
  • [42] Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
    Adepoju, Victor A.
    [J]. BREATHE, 2019, 15 (04) : 353 - 355
  • [43] Acetazolamide use in severe COPD exacerbations requiring invasive mechanical ventilation: impact on duration of mechanical ventilation
    Bahloul, Mabrouk
    Chtara, Kamilia
    Chelly, Hedi
    Regaieg, Kais
    Chaari, Anis
    Bouaziz, Mounir
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (05) : 762 - 764
  • [44] Risk factors of in-hospital mortality and discriminating capacity of NIVO score in exacerbations of COPD requiring noninvasive ventilation
    Zhang, Jiarui
    Yi, Qun
    Zhou, Chen
    Luo, Yuanming
    Wei, Hailong
    Ge, Huiqing
    Liu, Huiguo
    Zhang, Jianchu
    Li, Xianhua
    Xie, Xiufang
    Pan, Pinhua
    Yi, Mengqiu
    Cheng, Lina
    Zhou, Hui
    Liu, Liang
    Aili, Adila
    Liu, Yu
    Peng, Lige
    Pu, Jiaqi
    Zhou, Haixia
    [J]. CHRONIC RESPIRATORY DISEASE, 2024, 21
  • [45] Non-invasive ventilation for COPD exacerbations in daily clinical practice
    Elshof, J.
    Van der Pouw, A.
    Fikkers, E.
    Vos, P. J.
    Wijkstra, P. J.
    Duiverman, M. L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [46] The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
    Goodall, Louise
    Cochrane, Belinda
    Foo, Soo Wei
    Phong Nguyen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [47] Ward-Based Non-Invasive Ventilation in Acute Exacerbations of COPD: A Narrative Review of Current Practice and Outcomes in the UK
    Trethewey, Samuel P.
    Edgar, Ross G.
    Turner, Alice M.
    Mukherjee, Rahul
    [J]. HEALTHCARE, 2018, 6 (04)
  • [48] Uptake of Clinical Prognostic Tools in COPD Exacerbations Requiring Hospitalisation
    Lane, Nicholas D.
    Gillespie, Sarah M.
    Steer, John
    Bourke, Stephen C.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 18 (04) : 406 - 410
  • [49] Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
    Oshagbemi, Olorunfemi A.
    Franssen, Frits M. E.
    Braeken, Dionne C. W.
    Henskens, Yvonne
    Wouters, Emiel F. M.
    Maitland-van der Zee, Anke-Hilse
    Burden, Andrea M.
    de Vries, Frank
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (11) : 1191 - 1199
  • [50] Noninvasive ventilation in acute exacerbations of chronic obstructive pulmonary disease in patients with and without home noninvasive ventilation
    Hilbert, G
    Vargas, F
    Valentino, R
    Gruson, D
    Gbikpi-Benissan, G
    Cardinaud, JP
    Guenard, H
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (07) : 1453 - 1458